We are live on ! Find out more
ARMP icon

Armata Pharmaceuticals
ARMP

15 hedge funds and large institutions have $3.77M invested in Armata Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

6% more capital invested

Capital invested by funds: $3.57M → $3.77M (+$206K)

12% less funds holding

Funds holding: 17 → 15 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TS
Third Security
Virginia
+$706K
2
PAM
Panagora Asset Management
Massachusetts
+$80.2K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$41K
4
Goldman Sachs
Goldman Sachs
New York
+$25.1K
5
VKH
Virtu KCG Holdings
New York
+$16.8K

Top Sellers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$370K
2
SM
Sabby Management
Florida
-$152K
3
Citadel Advisors
Citadel Advisors
Florida
-$16K
4
MLM
Mount Lucas Management
Pennsylvania
-$11K
5
Morgan Stanley
Morgan Stanley
New York
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
TS
1
Third Security
Virginia
$2.41M +$706K +3,061 +37%
SM
2
Sabby Management
Florida
$782K -$152K -660 -15%
MP
3
MSD Partners
New York
$228K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$141K +$41K +178 +36%
PAM
5
Panagora Asset Management
Massachusetts
$68K +$80.2K +348 New
VKH
6
Virtu KCG Holdings
New York
$38K +$16.8K +73 +68%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$26K – – –
Renaissance Technologies
8
Renaissance Technologies
New York
$26K +$1.38K +6 +5%
FWM
9
Focused Wealth Management
New York
$24K +$2.54K +11 New
Goldman Sachs
10
Goldman Sachs
New York
$23K +$25.1K +109 New
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$3K – – –
TJHA
12
Thomas J. Herzfeld Advisors
Florida
$2K – – –
LTFS
13
Ladenburg Thalmann Financial Services
Florida
$1K – – –
BFA
14
BlackRock Fund Advisors
California
$1K +$230 +1 +20%
Hudson Bay Capital Management
15
Hudson Bay Capital Management
Connecticut
– -$370K -1,704 Closed
Citadel Advisors
16
Citadel Advisors
Florida
– -$16K -75 Closed
MLM
17
Mount Lucas Management
Pennsylvania
– -$11K -52 Closed
Morgan Stanley
18
Morgan Stanley
New York
– -$3K -16 Closed

ARMP Hedge Fund Activity: Q3 2016 in Review

15 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q3 2016, worth a combined $3.77M — up 5.8% from $3.57M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ARMP and 3 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 5 added.

The largest buyer was Third Security, adding an estimated $706K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $370K sold.

  • 15 institutional investors held Armata Pharmaceuticals (ARMP) as of Q3 2016, down from 17 in Q2 2016.
  • Funds reported $3.77M of Armata Pharmaceuticals stock for Q3 2016, up 5.8% quarter-over-quarter.
  • 3 funds opened new Armata Pharmaceuticals positions in Q3 2016 and 5 closed out, a net change of -2 holders.
  • The largest Armata Pharmaceuticals buyer in Q3 2016 was Third Security, an estimated $706K added.
  • The largest Armata Pharmaceuticals seller in Q3 2016 was Hudson Bay Capital Management, an estimated $370K sold.

Based on aggregated 13F filings for Q3 2016.